Cara Flynn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cara Flynn has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Adam Wright
Department of Respiratory Sciences, University of Leicester, Leicester, UK
2 shared publications Hnin Aung
Department of Respiratory Sciences, University of Leicester, Leicester, UK
2 shared publications- Neil J. Greening
The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK
2 shared publications Aleksandra (Ola) Howell
University of Oxford Nuffield Department of Primary Care Health Sciences, Oxford, England, UK
1 shared publication- Anna Murphy
Dept of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK
1 shared publication Anthony W Martinelli
Royal Papworth Hospital NHS Foundation Trust, University of Cambridge, Cambridge, UK, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
1 shared publication
Latest Publications
Review of the British Thoracic Society Winter Meeting 26–29 November 2025
Background: The 2025 British Thoracic Society (BTS) Winter Meeting delivered 3 days of cutting-edge science, clinical innovation and networking in wintry Westminster. Over 2500 attendees from 36 countries gathered to share advances shaping the future of respiratory medicine. Content: The programme opened with a session focused on emerging clinical trial data, showcasing pragmatic and mechanistic studies designed to address real-world challenges in respiratory care, setting the tone for a meeting focused on impact and innovation. Translational research featured strongly throughout the meeting, with organoids, precision-cut lung slices and air-liquid interface cultures providing new perspectives on disease mechanisms and therapeutic targets. Early career investigators presented discoveries in eosinophilic chronic obstructive pulmonary disease biology, microbiome-driven viral susceptibility and resistance risks in novel bronchiectasis therapies, while midcareer leaders advanced understanding of familial interstitial lung disease and virus–host interactions. Plenary sessions tackled pressing challenges, from air pollution and breathlessness diagnostics to genetic drivers of pulmonary hypertension, complemented by guest lectures on immune regulation, vaccine-preventable illness and drug discovery. Additionally, the meeting highlighted workforce transformation, emphasising the role of nurses, allied health professionals and pharmacists in delivering integrated, digitally enabled care. Conclusion: Reminding us that progress rests on both scientific endeavour and enduring professional bonds, the 2025 BTS Winter Meeting reaffirmed that respiratory research is for everyone—an essential driver of advancement across disciplines. Multidisciplinary working and inclusive engagement will be key to shaping future care and ensuring that innovation translates into better outcomes for patients worldwide.
Review of the British Thoracic Society Winter Meeting 26–29 November 2025
Background: The 2025 British Thoracic Society (BTS) Winter Meeting delivered 3 days of cutting-edge science, clinical innovation and networking in wintry Westminster. Over 2500 attendees from 36 countries gathered to share advances shaping the future of respiratory medicine. Content: The programme opened with a session focused on emerging clinical trial data, showcasing pragmatic and mechanistic studies designed to address real-world challenges in respiratory care, setting the tone for a meeting focused on impact and innovation. Translational research featured strongly throughout the meeting, with organoids, precision-cut lung slices and air-liquid interface cultures providing new perspectives on disease mechanisms and therapeutic targets. Early career investigators presented discoveries in eosinophilic chronic obstructive pulmonary disease biology, microbiome-driven viral susceptibility and resistance risks in novel bronchiectasis therapies, while midcareer leaders advanced understanding of familial interstitial lung disease and virus–host interactions. Plenary sessions tackled pressing challenges, from air pollution and breathlessness diagnostics to genetic drivers of pulmonary hypertension, complemented by guest lectures on immune regulation, vaccine-preventable illness and drug discovery. Additionally, the meeting highlighted workforce transformation, emphasising the role of nurses, allied health professionals and pharmacists in delivering integrated, digitally enabled care. Conclusion: Reminding us that progress rests on both scientific endeavour and enduring professional bonds, the 2025 BTS Winter Meeting reaffirmed that respiratory research is for everyone—an essential driver of advancement across disciplines. Multidisciplinary working and inclusive engagement will be key to shaping future care and ensuring that innovation translates into better outcomes for patients worldwide.
- Open Access
- 1 October 2024
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 33 (174) , 240136
Digital remote maintenance inhaler adherence interventions in COPD: a systematic review and meta-analysis
Introduction: Sub-optimal inhaler adherence undermines the efficacy of pharmacotherapy in COPD. Digitalised care pathways are increasingly used to improve inhaler-use behaviour remotely. This review investigated the feasibility and impact of remote electronic inhaler adherence monitoring (EIM) and intervention platforms on clinical outcomes in COPD.Methods: A literature search was conducted and studies investigating maintenance inhaler use among people with COPD using digital technology were selected. Pairwise and proportional meta-analyses were employed with heterogeneity assessed using I2statistics. When meta-analysis was not feasible, a narrative synthesis of outcomes was conducted.Results: We included 10 studies including 1432 people with COPD whose maintenance inhaler usage was supported by digital inhalers and apps featuring audiovisual reminders and educational content with or without engagement with healthcare providers (HCPs). Inhaler adherence rate (AR) varied with calculation methods, but an overall suboptimal adherence was observed among people with COPD. HCP-led adherence interventions alongside EIM improved mean AR by 18% (95% CI 9–27)versuspassive EIM only. Enhanced AR may reduce COPD-related healthcare utilisation with little impact on health-related quality of life and exacerbation rate. Despite encountering technical issues among 14% (95% CI 5–23%) of participants, 85% (95% CI 76–94%) found digital platforms convenient to use, while 91% (95% CI 79–100%) perceived inhaler reminders as helpful.Conclusion: Digitalised interventions can enhance maintenance inhaler adherence in COPD but their overall effect on clinical outcomes remains uncertain. Further work is required to tailor interventions to individuals’ adherence behaviour and investigate their longer-term impact.
- 1 October 2024
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 33 (174) , 240136
Open AccessDigital remote maintenance inhaler adherence interventions in COPD: a systematic review and meta-analysis
Introduction: Sub-optimal inhaler adherence undermines the efficacy of pharmacotherapy in COPD. Digitalised care pathways are increasingly used to improve inhaler-use behaviour remotely. This review investigated the feasibility and impact of remote electronic inhaler adherence monitoring (EIM) and intervention platforms on clinical outcomes in COPD.Methods: A literature search was conducted and studies investigating maintenance inhaler use among people with COPD using digital technology were selected. Pairwise and proportional meta-analyses were employed with heterogeneity assessed using I2statistics. When meta-analysis was not feasible, a narrative synthesis of outcomes was conducted.Results: We included 10 studies including 1432 people with COPD whose maintenance inhaler usage was supported by digital inhalers and apps featuring audiovisual reminders and educational content with or without engagement with healthcare providers (HCPs). Inhaler adherence rate (AR) varied with calculation methods, but an overall suboptimal adherence was observed among people with COPD. HCP-led adherence interventions alongside EIM improved mean AR by 18% (95% CI 9–27)versuspassive EIM only. Enhanced AR may reduce COPD-related healthcare utilisation with little impact on health-related quality of life and exacerbation rate. Despite encountering technical issues among 14% (95% CI 5–23%) of participants, 85% (95% CI 76–94%) found digital platforms convenient to use, while 91% (95% CI 79–100%) perceived inhaler reminders as helpful.Conclusion: Digitalised interventions can enhance maintenance inhaler adherence in COPD but their overall effect on clinical outcomes remains uncertain. Further work is required to tailor interventions to individuals’ adherence behaviour and investigate their longer-term impact.
- Open Access
- 27 June 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (5)
Post-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in the COPD population
The impact of seasonality on the morbidity due to acute exacerbations of COPD (AECOPD) is well recognised, with winter months typically associated with increased respiratory infections and healthcare utilisation among the COPD population [1]. The first wave of the coronavirus disease 2019 (COVID-19) pandemic saw at least 50% decline in AECOPD admissions associated with fewer viral triggers [2]. However, after relaxation of lockdown measures, it is unknown if there has been a longer-term shift in the seasonal pattern of AECOPD hospitalisations and their specific aetiologies, considering the heterogeneity behind exacerbations. This information may help healthcare providers prepare targeted preventative measures and resource allocation.
- 27 June 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (5)
Open AccessPost-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in the COPD population
The impact of seasonality on the morbidity due to acute exacerbations of COPD (AECOPD) is well recognised, with winter months typically associated with increased respiratory infections and healthcare utilisation among the COPD population [1]. The first wave of the coronavirus disease 2019 (COVID-19) pandemic saw at least 50% decline in AECOPD admissions associated with fewer viral triggers [2]. However, after relaxation of lockdown measures, it is unknown if there has been a longer-term shift in the seasonal pattern of AECOPD hospitalisations and their specific aetiologies, considering the heterogeneity behind exacerbations. This information may help healthcare providers prepare targeted preventative measures and resource allocation.
- Open Access
- 14 February 2024
- Published by Springer Nature
Effects of blocking a messaging protein called TSLP (thymic stromal lymphopoietin) on inflammation in the airways
- 14 February 2024
- Published by Springer Nature
Open AccessEffects of blocking a messaging protein called TSLP (thymic stromal lymphopoietin) on inflammation in the airways